© 2022 MJH Life Sciences and Drug Topics. All rights reserved.
© 2022 MJH Life Sciences™ and Drug Topics. All rights reserved.
March 03, 2022
Pharmacists are well positioned to address the care issues faced by patients living with autoimmune diseases.
February 14, 2022
While the use of combined oral contraceptives in patients with rheumatoid and autoimmune disorders have focused on safety, a recent narrative review highlighted the efficacy and benefits of these contraceptives in women with RA.
February 04, 2022
Managing autoimmune conditions like type 1 diabetes, rheumatoid arthritis, and lupus during pregnancy can present challenges for patients and physicians.
January 21, 2022
Healthcare professionals need to make patients the primary decision-makers in their own care and actively support their efforts to achieve their care goals.
January 05, 2022
Emerging evidence is changing health care providers’ approach to treating pediatric rheumatic diseases.
November 11, 2021
Investigators supplemented a slim body of existing research on CBD for pain management.
November 09, 2021
A study presented at ACR Convergence 2021 examined the relationship between race/ethnicity, living in a disadvantaged neighborhood, and how often patients are prescribed disease-specific treatments.
August 26, 2021
Drug Topics® sat down with Dr. Daniel Streetman, PharmD, to discuss patients with compromised immune systems and reported responses to COVID-19 vaccines and others.
August 10, 2021
Pharmacists can educate patients on psoriasis treatments and lifestyle modifications, address expected drug-related adverse effects (AEs), and improve medication adherence.
August 02, 2021
Anifrolumab (Saphnelo; AstraZeneca) significantly improves disease activity and reduces corticosteroid use in patients with SLE.